van Teunenbroek, Kim C., Mulder, Renée L., Ahout, Inge M. L., Bindels-de Heus, Karen G. C. B., Delsman-van Gelder, Catharina M., Galimont-Collen, Annemie F. S., de Groot, Marinka A. R., Heitink-Polle, Katja M. J., Looijestijn, Jeffry, Mensink, Maarten O., Mulder, Selma, Schieving, Jolanda H., Schouten-van Meeteren, Antoinette Y. N., Verheijden, Johannes M. A., Rippen, Hester, Borggreve, Brigitt C. M., Kremer, Leontien C. M., Verhagen, A. A. Eduard, Michiels, Erna M. C., and on behalf of the working groups symptom treatment and refractory symptom treatment of the Dutch paediatric palliative care guideline
Background: Children with life-threatening and life-limiting conditions can experience high levels of suffering due to multiple distressing symptoms that result in poor quality of life and increase risk of long-term distress in their family members. High quality symptom treatment is needed for all these children and their families, even more so at the end-of-life. In this paper, we provide evidence-based recommendations for symptom treatment in paediatric palliative patients to optimize care. Methods: A multidisciplinary panel of 56 experts in paediatric palliative care and nine (bereaved) parents was established to develop recommendations on symptom treatment in paediatric palliative care including anxiety and depression, delirium, dyspnoea, haematological symptoms, coughing, skin complaints, nausea and vomiting, neurological symptoms, pain, death rattle, fatigue, paediatric palliative sedation and forgoing hydration and nutrition. Recommendations were based on evidence from a systematic literature search, additional literature sources (such as guidelines), clinical expertise, and patient and family values. We used the GRADE methodology for appraisal of evidence. Parents were included in the guideline panel to ensure the representation of patient and family values. Results: We included a total of 18 studies that reported on the effects of specific (non) pharmacological interventions to treat symptoms in paediatric palliative care. A few of these interventions showed significant improvement in symptom relief. This evidence could only (partly) answer eight out of 27 clinical questions. We included 29 guidelines and two textbooks as additional literature to deal with lack of evidence. In total, we formulated 221 recommendations on symptom treatment in paediatric palliative care based on evidence, additional literature, clinical expertise, and patient and family values. Conclusion: Even though available evidence on symptom-related paediatric palliative care interventions has increased, there still is a paucity of evidence in paediatric palliative care. We urge for international multidisciplinary multi-institutional collaboration to perform high-quality research and contribute to the optimization of symptom relief in palliative care for all children worldwide. [ABSTRACT FROM AUTHOR]